Mesenchymal Stromal Cell-derived Extracellular Vesicles: Novel Approach in Hematopoietic Stem Cell Transplantation

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2022 May 16

PMID 35578300

Authors

Davod Pashoutan Sarvar

Hosein Effatpanah

Parvin Akbarzadehlaleh

Karim Shamsasenjan

Affiliations

Soon will be listed here.

Abstract

Bone marrow mesenchymal stromal cells (MSCs) play a crucial role in the regulation of hematopoiesis. These cells affect the process through direct cell-cell contact, as well as releasing various trophic factors and extracellular vehicles (EVs) into the bone marrow microenvironment. MSC-derived EVs (MSC-EVs) are prominent intercellular communication tolls enriched with broad-spectrum bioactive factors such as proteins, cytokines, lipids, miRNAs, and siRNAs. They mimic some effects of MSCs by direct fusion with hematopoietic stem cells (HSC) membranes in the bone marrow (BM), thereby affecting HSC fate. MSC-EVs are attractive scope in cell-free therapy because of their unique capacity to repair BM tissue and regulate proliferation and differentiation of HSCs. These vesicles modulate the immune system responses and inhibit graft-versus-host disease following hematopoietic stem cell transplantation (HSCT). Recent studies have demonstrated that MSC-EVs play an influential role in the BM niches because of their unprecedented capacity to regulate HSC fate. Therefore, the existing paper intends to speculate upon the preconditioned MSC-EVs as a novel approach in HSCT.

Citing Articles

Global microRNA profiling of bone marrow-MSC derived extracellular vesicles identifies miRNAs associated with hematopoietic dysfunction in aplastic anemia.

Srivastava J, Kundal K, Rai B, Saxena P, Katiyar S, Tripathy N Sci Rep. 2024; 14(1):19654.

PMID: 39179703 PMC: 11343855. DOI: 10.1038/s41598-024-70369-8.

The role of the hematopoietic stem/progenitor cells-derived extracellular vesicles in hematopoiesis.

Fathi E, Valipour B, Jafari S, Kazemi A, Montazersaheb S, Farahzadi R Heliyon. 2024; 10(15):e35051.

PMID: 39157371 PMC: 11327835. DOI: 10.1016/j.heliyon.2024.e35051.

Extracellular vesicles as tools and targets in therapy for diseases.

Kumar M, Baba S, Sadida H, Al Marzooqi S, Jerobin J, Altemani F Signal Transduct Target Ther. 2024; 9(1):27.

PMID: 38311623 PMC: 10838959. DOI: 10.1038/s41392-024-01735-1.

Adipose-Derived Mesenchymal Stem Cell Facilitate Hematopoietic Stem Cell Proliferation via the Jagged-1/Notch-1/Hes Signaling Pathway.

Wang H, Bi X, Zhang R, Yuan H, Xu J, Zhang K Stem Cells Int. 2023; 2023:1068405.

PMID: 38020206 PMC: 10653966. DOI: 10.1155/2023/1068405.

Differential Expression of the hTERT Gene in Umbilical Cord-Derived Mesenchymal Stem Cells Cocultured with B Cell Precursor Leukemia Cell Microparticles or CD41/CD61 Platelet Microparticles.

Yari F, Ashoub M, Amirizadeh N, Nikougoftar M, Mardani Valandani H, Mirzaee Khalilabadi R Biochem Genet. 2023; 62(4):2796-2809.

PMID: 38019337 DOI: 10.1007/s10528-023-10565-9.

References

Molaeipour Z, Shamsasanjan K, Movassaghpour A, Akbarzadehlaleh P, Sabaghi F, Saleh M . The Effect of Bone Marrow Mesenchymal Stem Cells on Vitamin D3 Induced Monocytic Differentiation of U937 Cells. Adv Pharm Bull. 2016; 6(1):23-29. PMC: 4845548. DOI: 10.15171/apb.2016.05. View

Borger V, Bremer M, Ferrer-Tur R, Gockeln L, Stambouli O, Becic A . Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents. Int J Mol Sci. 2017; 18(7). PMC: 5535941. DOI: 10.3390/ijms18071450. View

Budgude P, Kale V, Vaidya A . Mesenchymal stromal cell-derived extracellular vesicles as cell-free biologics for the ex vivo expansion of hematopoietic stem cells. Cell Biol Int. 2020; 44(5):1078-1102. DOI: 10.1002/cbin.11313. View

Goloviznina N, Verghese S, Yoon Y, Taratula O, Marks D, Kurre P . Mesenchymal Stromal Cell-derived Extracellular Vesicles Promote Myeloid-biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement. J Biol Chem. 2016; 291(47):24607-24617. PMC: 5114412. DOI: 10.1074/jbc.M116.745653. View

El Andaloussi S, Mager I, Breakefield X, Wood M . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-57. DOI: 10.1038/nrd3978. View

Wang Y, Zhang Z, Chi Y, Zhang Q, Xu F, Yang Z . Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis. 2013; 4:e950. PMC: 3877551. DOI: 10.1038/cddis.2013.480. View

Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

Ghebes C, Morhayim J, Kleijer M, Koroglu M, Erkeland S, Hoogenboezem R . Extracellular Vesicles Derived From Adult and Fetal Bone Marrow Mesenchymal Stromal Cells Differentially Promote Expansion of Hematopoietic Stem and Progenitor Cells. Front Bioeng Biotechnol. 2021; 9:640419. PMC: 7947881. DOI: 10.3389/fbioe.2021.640419. View

Jing D, Fonseca A, Alakel N, Fierro F, Muller K, Bornhauser M . Hematopoietic stem cells in co-culture with mesenchymal stromal cells--modeling the niche compartments in vitro. Haematologica. 2010; 95(4):542-50. PMC: 2857183. DOI: 10.3324/haematol.2009.010736. View

10.

Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G . Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS One. 2013; 8(8):e71412. PMC: 3734067. DOI: 10.1371/journal.pone.0071412. View

11.

Hu H, Wang D, Li L, Yin H, He G, Zhang Y . Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery. Cell Death Dis. 2021; 12(2):156. PMC: 7862274. DOI: 10.1038/s41419-021-03430-3. View

12.

Yin K, Wang S, Zhao R . Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res. 2019; 7:8. PMC: 6450000. DOI: 10.1186/s40364-019-0159-x. View

13.

Bruno S, Collino F, Deregibus M, Grange C, Tetta C, Camussi G . Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev. 2012; 22(5):758-71. DOI: 10.1089/scd.2012.0304. View

14.

Leisten I, Kramann R, Ventura Ferreira M, Bovi M, Neuss S, Ziegler P . 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials. 2011; 33(6):1736-47. DOI: 10.1016/j.biomaterials.2011.11.034. View

15.

Kupcova Skalnikova H, Bohuslavova B, Turnovcova K, Juhasova J, Juhas S, Rodinova M . Isolation and Characterization of Small Extracellular Vesicles from Porcine Blood Plasma, Cerebrospinal Fluid, and Seminal Plasma. Proteomes. 2019; 7(2). PMC: 6630935. DOI: 10.3390/proteomes7020017. View

16.

Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q . Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. Cell Death Differ. 2016; 23(7):1128-39. PMC: 4946886. DOI: 10.1038/cdd.2015.168. View

17.

Cavallero S, Riccobono D, Drouet M, Francois S . MSC-Derived Extracellular Vesicles: New Emergency Treatment to Limit the Development of Radiation-Induced Hematopoietic Syndrome?. Health Phys. 2020; 119(1):21-36. DOI: 10.1097/HP.0000000000001264. View

18.

Kallekleiv M, Larun L, Bruserud O, Hatfield K . Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Cytotherapy. 2016; 18(2):172-85. DOI: 10.1016/j.jcyt.2015.11.010. View

19.

Maumus M, Jorgensen C, Noel D . Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie. 2013; 95(12):2229-34. DOI: 10.1016/j.biochi.2013.04.017. View

20.

Nikkhah H, Safarzadeh E, Shamsasenjan K, Yousefi M, Lotfinejad P, Talebi M . The Effect of Bone Marrow Mesenchymal Stem Cells on the Granulocytic Differentiation of HL-60 Cells. Turk J Haematol. 2017; 35(1):42-48. PMC: 5843773. DOI: 10.4274/tjh.2016.0498. View